A common kidney medication could be the key to treating a type of infertility that affects up to 3% of women under 40, according to a study published in Science.
Premature ovarian insufficiency (POI) is a condition where the ovaries stop functioning properly, leading to low estrogen levels and follicles that often fail to develop or respond to fertility treatments. This leaves the eggs in a dormant state. Current treatments are limited to managing symptoms such as hot flashes and night sweats.
For years, scientists focused on the eggs themselves, but researchers led by Tianren Wang and Kui Liu from the University of Hong Kong suspected the problem could be the environment the eggs live in (the ovarian stroma).









